MOH Form 4: Director Ronna Romney receives 285 shares worth $55,000

Rhea-AI Filing Summary

The filing shows that Ronna Romney, a director of Molina Healthcare, Inc. (MOH), received an equity grant under the company’s 2025 Equity Incentive Plan on 10/01/2025. The award represents a quarterly portion of the director annual equity retainer of $220,000, with one quarter equal to $55,000. Based on the closing stock price of $192.79 on the grant date, the grant comprised 285 shares.

After the grant, the filing reports 17,416 shares beneficially owned by Ms. Romney, held indirectly through the Ronna Romney Revocable Trust. The Form 4 was signed by a power of attorney on 10/02/2025. The disclosure is a routine director equity compensation report and records the grant price and the indirect ownership vehicle.

Positive

• Director equity compensation disclosed: Award clearly documented as part of the 2025 Equity Incentive Plan and tied to the annual retainer of $220,000.
• Transparent valuation: Grant calculated using the explicit closing price of $192.79 on 10/01/2025, producing 285 shares.

Negative

• None.

Insights

Corporate Governance & Compensation Analyst

Routine director equity award: $55,000 quarterly tranche produced 285 shares at $192.79.

The grant is part of the company’s standard 2025 Equity Incentive Plan director retainer structure totaling $220,000 annually, paid in quarterly tranches of $55,000. The reported grant date and closing price are explicitly disclosed, producing a concrete share count of 285.

The filing also confirms continued indirect beneficial ownership of 17,416 shares via the Ronna Romney Revocable Trust, which is relevant for assessing total insider holdings and potential voting influence.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ROMNEY RONNA

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		285(2)	A	$192.79(3)	17,416	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

3. Represents the closing price of the Issuer's common stock on October 1, 2025.

4. All shares held by Ronna Romney Revocable Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Ronna Romney.	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ronna Romney report on Form 4 for MOH?

The Form 4 reports a director equity grant of 285 shares on 10/01/2025, granted as a quarterly portion ($55,000) of the annual $220,000 retainer under the 2025 Equity Incentive Plan.

What price was used to calculate the director grant for MOH?

The grant was calculated using the closing price of $192.79 per share on 10/01/2025.

How many MOH shares does Ronna Romney beneficially own after the grant?

The filing reports 17,416 shares beneficially owned, held indirectly by the Ronna Romney Revocable Trust.

Was the Form 4 signed directly by Ronna Romney?

The Form 4 was signed on behalf of Ronna Romney by Jeff D. Barlow under power of attorney on 10/02/2025.

Is this grant part of a recurring compensation schedule?

Yes. The filing states the director annual equity award is $220,000, with one quarter ($55,000) granted each quarter; this grant reflects the quarterly tranche.